Home > Financial Ratios > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
EV/EBIT

    Back to All Ratios
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year EV/EBIT History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/EBIT(x) 38.9425.3832.8950.8064.12

What is the latest EV/EBIT ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest EV/EBIT ratio of GLAXOSMITHKLINE PHARMACEUTICALS is 38.94 based on Mar2024 Consolidated results.
Year EV/EBIT
Mar202438.94
Mar202325.38
Mar202232.89
Mar202150.80
Mar202064.12

How is EV/EBIT of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years EV/EBIT % Change
Mar2024 38.94
53.43
Mar2023 25.38
-22.83
Mar2022 32.89
-35.26
Mar2021 50.8
-20.77
Mar2020 64.12 -

Other Financial Ratios of GLAXOSMITHKLINE PHARMACEUTICALS


Compare EV/EBIT ratio of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹48,238.3 Cr -3.8% 2.6% 35% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,406.0 Cr -2.7% 3.9% 19.8% Stock Analytics
DIVIS LABORATORIES ₹163,113.0 Cr 1% 8.5% 55.3% Stock Analytics
CIPLA ₹121,869.0 Cr -2.6% 3.9% 6.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹111,345.0 Cr -0.7% 2.5% 22.3% Stock Analytics
DR REDDYS LABORATORIES ₹96,801.0 Cr -1.9% 0.9% -7.8% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

-3.8%

2.6%

35%

SENSEX

0.6%

6.2%

8.4%


You may also like the below Video Courses